1.
Belgian IBD research group (BIRD) position statement 2017 on the use of biosimilars in inflammatory bowel diseases (IBD).
2.
3.
4.
5.
6.
Determinants of prescribing decisions for off-patent biological medicines in Belgium: a qualitative study
7.
8.
9.
The impact of policy interventions to promote the uptake of biosimilar medicines in Belgium: a nationwide interrupted time series analysis
Additional file 1 of Knowledge and perception of biosimilars in ambulatory care: a survey among Belgian community pharmacists and physicians
Additional file 2 of Knowledge and perception of biosimilars in ambulatory care: a survey among Belgian community pharmacists and physicians
Additional file 3 of Knowledge and perception of biosimilars in ambulatory care: a survey among Belgian community pharmacists and physicians